MA27908A1 - Agents therapeutiques utiles pour le traitement de la douleur - Google Patents
Agents therapeutiques utiles pour le traitement de la douleurInfo
- Publication number
- MA27908A1 MA27908A1 MA28715A MA28715A MA27908A1 MA 27908 A1 MA27908 A1 MA 27908A1 MA 28715 A MA28715 A MA 28715A MA 28715 A MA28715 A MA 28715A MA 27908 A1 MA27908 A1 MA 27908A1
- Authority
- MA
- Morocco
- Prior art keywords
- pain
- treatment
- therapeutic agents
- agents useful
- hetero
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Addiction (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
AGENTS THERAPEUTIQUES POUR LE TRAITEMENT DE LA DOULEUR Un compose de formule: oé Ar1, Ar2, V, X, R3, R4, et m sont révélés dans ce texte ou un sel acceptable d'un point de vue pharmaceutique du ("composé Cyclo(hétéro)alkényle"); des compositions comprenant une quantité efficace d'un composé Cyclo(hétéro)alkényle; et des procédés pour le traitement et la prévention, par exemple, de la douleur, UI, d'un ulcère, IBD, ou IBS chez un animal, comprenant l'administration à un animal qui en a besoin d'une quantité efficace d'un composé Cyclo(hétéro)alkényle.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47774403P | 2003-06-12 | 2003-06-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA27908A1 true MA27908A1 (fr) | 2006-05-02 |
Family
ID=34061917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA28715A MA27908A1 (fr) | 2003-06-12 | 2006-01-09 | Agents therapeutiques utiles pour le traitement de la douleur |
Country Status (28)
Country | Link |
---|---|
US (3) | US7683063B2 (fr) |
EP (3) | EP2060260A1 (fr) |
JP (2) | JP5269315B2 (fr) |
KR (2) | KR100896497B1 (fr) |
CN (2) | CN101863877A (fr) |
AR (1) | AR044688A1 (fr) |
AT (2) | ATE413385T1 (fr) |
AU (1) | AU2004255169B2 (fr) |
BR (1) | BRPI0411241A (fr) |
CA (1) | CA2528920C (fr) |
CY (1) | CY1108738T1 (fr) |
DE (2) | DE602004017658D1 (fr) |
DK (1) | DK1862458T3 (fr) |
EA (1) | EA009593B1 (fr) |
ES (1) | ES2317623T3 (fr) |
GE (1) | GEP20084488B (fr) |
IL (1) | IL172418A (fr) |
IS (1) | IS8142A (fr) |
MA (1) | MA27908A1 (fr) |
MX (1) | MXPA05013587A (fr) |
MY (1) | MY142655A (fr) |
NO (1) | NO20060192L (fr) |
PL (1) | PL1862458T3 (fr) |
PT (1) | PT1862458E (fr) |
SI (1) | SI1862458T1 (fr) |
TW (1) | TWI287010B (fr) |
WO (1) | WO2005004866A1 (fr) |
ZA (1) | ZA200508744B (fr) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE452637T1 (de) | 2001-01-29 | 2010-01-15 | Shionogi & Co | Arzneipräparat, das als wirkstoff 5-methyl-1- phenyl-2-(1h)-pyridon enthält |
WO2004103954A1 (fr) | 2003-05-20 | 2004-12-02 | Ajinomoto Co., Inc. | Derive d'amide |
TWI287010B (en) | 2003-06-12 | 2007-09-21 | Euro Celtique Sa | Therapeutic agents useful for treating pain |
US20050009841A1 (en) * | 2003-07-11 | 2005-01-13 | Zheng Guo Zhu | Novel amides useful for treating pain |
DK1648878T3 (da) * | 2003-07-24 | 2009-08-10 | Euro Celtique Sa | Piperidinforbindelser og farmaceutiske sammensætninger, som indeholder dem |
NZ544009A (en) | 2003-07-24 | 2009-07-31 | Euro Celtique Sa | Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain |
TW200738232A (en) * | 2006-01-31 | 2007-10-16 | Alcon Mfg Ltd | Use of vanilloid receptor-1 antagonists for the prevention and treatment of glaucoma |
US20080051380A1 (en) | 2006-08-25 | 2008-02-28 | Auerbach Alan H | Methods and compositions for treating cancer |
KR100801278B1 (ko) * | 2006-08-29 | 2008-02-04 | 삼성전기주식회사 | 하이브리드형 광도파로 센서 |
US7645767B2 (en) * | 2006-08-31 | 2010-01-12 | Trinity Laboratories, Inc. | Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy |
WO2008057300A2 (fr) * | 2006-10-27 | 2008-05-15 | Redpoint Bio Corporation | Antagonistes de trpvi et leurs utilisations |
KR20090130422A (ko) | 2007-04-27 | 2009-12-23 | 퍼듀 퍼머 엘피 | 통증 치료에 유용한 치료제 |
PL2142529T3 (pl) * | 2007-04-27 | 2014-06-30 | Purdue Pharma Lp | Antagoniści trpv1 i ich zastosowania |
CA2684105C (fr) | 2007-05-03 | 2011-09-06 | Pfizer Limited | Derives de la pyridine |
US7998982B2 (en) | 2007-08-09 | 2011-08-16 | Abbott Laboratories | Amide derivatives as TRPV1 antagonists |
US8084616B2 (en) | 2007-10-24 | 2011-12-27 | Abbott Laboratories | TRPV1 antagonists |
BRPI0913642A2 (pt) | 2008-06-30 | 2015-11-24 | Novartis Ag | produtos de combinação |
US8921373B2 (en) | 2010-06-22 | 2014-12-30 | Shionogi & Co., Ltd. | Compounds having TRPV1 antagonistic activity and uses thereof |
EP2709609B1 (fr) | 2011-05-17 | 2017-10-04 | Shionogi & Co., Ltd. | Composés hétérocycliques |
MY185061A (en) | 2011-06-22 | 2021-04-30 | Shionogi & Co | Trpv1 antagonists including dihydroxy substituent and uses thereof |
WO2013146970A1 (fr) * | 2012-03-29 | 2013-10-03 | 第一三共株式会社 | Nouveau dérivé de quinoléine |
TW201730188A (zh) * | 2015-11-30 | 2017-09-01 | 阿斯特捷利康公司 | 1,3,4-噻二唑化合物及其在治療癌症中之用途 |
CA2937365C (fr) | 2016-03-29 | 2018-09-18 | F. Hoffmann-La Roche Ag | Formulation en granules de 5-methyl-1-phenyl-2-(1h)-pyridone et methode de fabrication associee |
TWI808055B (zh) | 2016-05-11 | 2023-07-11 | 美商滬亞生物國際有限公司 | Hdac 抑制劑與 pd-1 抑制劑之組合治療 |
TWI794171B (zh) | 2016-05-11 | 2023-03-01 | 美商滬亞生物國際有限公司 | Hdac抑制劑與pd-l1抑制劑之組合治療 |
BR112018076441A2 (pt) | 2016-06-23 | 2019-04-09 | St. Jude Children´S Research Hospital | moduladores de molécula pequena de pantotenato quinases |
KR20240115925A (ko) | 2016-07-29 | 2024-07-26 | 얀센 파마슈티카 엔브이 | 전립선암의 치료 방법 |
GB201709459D0 (en) * | 2017-06-14 | 2017-07-26 | Intrabio Ltd | Treatment for migraine |
JP6964506B2 (ja) * | 2017-12-19 | 2021-11-10 | ライオン株式会社 | 錠剤及び錠剤の製造方法 |
EP3731859A4 (fr) | 2017-12-27 | 2021-09-22 | St. Jude Children's Research Hospital, Inc. | Méthodes de traitement de troubles associés à castor |
CA3086671A1 (fr) | 2017-12-27 | 2019-07-04 | St. Jude Children's Research Hospital, Inc. | Modulateurs a petites molecules de pantothenate kinases |
RU2744162C1 (ru) * | 2020-03-18 | 2021-03-03 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермская государственная фармацевтическая академия" Министерства здравоохранения Российской Федерации (ФГБОУ ВО ПГФА Минздрава России) | Анальгетическое средство на основе 5-(2-аминопропил)-6-оксо-3,4-дифенилпирроло[3,4-c]пиразола |
CN115536648B (zh) * | 2021-06-29 | 2024-09-17 | 深圳开悦生命科技有限公司 | 一类抑制rna解旋酶dhx33的多环化合物及其应用 |
CN113061593B (zh) * | 2021-04-02 | 2023-11-10 | 洛阳华荣生物技术有限公司 | 一种l-苹果酸脱氢酶突变体及其应用 |
DE102022104759A1 (de) | 2022-02-28 | 2023-08-31 | SCi Kontor GmbH | Co-Kristall-Screening Verfahren, insbesondere zur Herstellung von Co-Kristallen |
CN114957214A (zh) * | 2022-06-22 | 2022-08-30 | 九江善水科技股份有限公司 | 一种氯虫苯甲酰胺中间体的制备方法 |
Family Cites Families (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3536809A (en) * | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
US3598123A (en) * | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
GB1363215A (en) * | 1973-01-04 | 1974-08-14 | Mullard Ltd | Mechanical-electrical transducer |
US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4008719A (en) * | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
US5053595A (en) * | 1982-12-01 | 1991-10-01 | Metcal, Inc. | Heat shrink sleeve with high mu material |
IE58110B1 (en) * | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
JPH0680054B2 (ja) | 1985-06-19 | 1994-10-12 | 吉富製薬株式会社 | ピペリジン誘導体 |
US5316759A (en) * | 1986-03-17 | 1994-05-31 | Robert J. Schaap | Agonist-antagonist combination to reduce the use of nicotine and other drugs |
DE3822792C2 (de) * | 1987-07-11 | 1997-11-27 | Sandoz Ag | Neue Verwendung von 5HT¶3¶-Antagonisten |
US5198459A (en) * | 1987-07-11 | 1993-03-30 | Sandoz Ltd. | Use of 5HT-3 antagonists in preventing or reducing dependency on dependency-inducing agents |
US5073543A (en) * | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
IT1229203B (it) | 1989-03-22 | 1991-07-25 | Bioresearch Spa | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. |
US5120548A (en) * | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
US5075341A (en) * | 1989-12-01 | 1991-12-24 | The Mclean Hospital Corporation | Treatment for cocaine abuse |
US5733566A (en) * | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
IL114690A (en) * | 1990-06-07 | 1997-02-18 | Wellcome Found | Antimigraine oxazolidinone substituted indole derivatives |
FR2676734B1 (fr) * | 1991-05-23 | 1995-05-19 | Roussel Uclaf | Nouveaux derives de la pyrimidine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant. |
US5698155A (en) * | 1991-05-31 | 1997-12-16 | Gs Technologies, Inc. | Method for the manufacture of pharmaceutical cellulose capsules |
US6204284B1 (en) * | 1991-12-20 | 2001-03-20 | American Cyanamid Company | Use of 1-(substitutedphenyl)-3-azabicyclo[3.1.0]hexanes for the treatment of chemical dependencies |
US5580578A (en) * | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
US5232934A (en) * | 1992-07-17 | 1993-08-03 | Warner-Lambert Co. | Method for the treatment of psychomotor stimulant addiction |
DE4234295A1 (de) * | 1992-10-12 | 1994-04-14 | Thomae Gmbh Dr K | Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
US5591767A (en) * | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
US5321012A (en) * | 1993-01-28 | 1994-06-14 | Virginia Commonwealth University Medical College | Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance |
IT1270594B (it) * | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
US5556837A (en) * | 1994-08-01 | 1996-09-17 | Regeneron Pharmaceuticals Inc. | Methods for treating addictive disorders |
US5762925A (en) * | 1994-11-03 | 1998-06-09 | Sagen; Jacqueline | Preventing opiate tolerance by cellular implantation |
EP0833622B8 (fr) * | 1995-06-12 | 2005-10-12 | G.D. Searle & Co. | Compositions comprenant un inhibiteur de cyclooxygenase-2 et un inhibiteur de 5-lipoxygenase |
US6063930A (en) * | 1996-04-03 | 2000-05-16 | Merck & Co., Inc. | Substituted imidazole compounds useful as farnesyl-protein transferase inhibitors |
WO1998025908A1 (fr) * | 1996-12-13 | 1998-06-18 | Banyu Pharmaceutical Co., Ltd. | Nouveaux derives d'aminopyrazole |
US6703362B1 (en) * | 1997-05-15 | 2004-03-09 | Cytogen Corporation | Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods |
ATE253111T1 (de) * | 1997-08-20 | 2003-11-15 | Univ California | Für den capsaicin rezeptor kodierende nukleinsäuresequenzen und dem capsaicin rezeptor ähnliche polypeptide und ihre verwendung |
EP0943683A1 (fr) * | 1998-03-10 | 1999-09-22 | Smithkline Beecham Plc | Homologue humain du récepteur vanilloide Vanilrep1 |
US6098369A (en) * | 1998-07-17 | 2000-08-08 | Bodolay; William A. | Apparatus for attaching a reclosable fastener to a flexible material |
WO2000039117A1 (fr) * | 1998-12-23 | 2000-07-06 | Eli Lilly And Company | AMIDES HETEROAROMATIQUES COMME INHIBITEURS DU FACTEUR Xa |
US6689780B1 (en) * | 1998-12-23 | 2004-02-10 | Eli Lilly And Company | Heteroroaromatic amides as inhibitor of factor Xa |
ES2226485T3 (es) * | 1998-12-23 | 2005-03-16 | Eli Lilly And Company | Amidas aromaticas. |
GB9907097D0 (en) * | 1999-03-26 | 1999-05-19 | Novartis Ag | Organic compounds |
US6632815B2 (en) * | 1999-09-17 | 2003-10-14 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
ATE402704T1 (de) | 2000-03-27 | 2008-08-15 | Abbott Gmbh & Co Kg | Dopamin-d3-rezeptor-liganden zur behandlung von sucht |
CA2407149C (fr) * | 2000-04-28 | 2010-10-12 | Takeda Chemical Industries, Ltd. | Antagonistes de l'hormone concentrant la melanine |
AR028782A1 (es) * | 2000-07-05 | 2003-05-21 | Taisho Pharmaceutical Co Ltd | Derivados heterociclicos tetrahidropiridino o piperidino |
JP2003142681A (ja) * | 2001-10-31 | 2003-05-16 | Sony Corp | 絶縁ゲート型電界効果トランジスタを有する半導体装置 |
JP2003192673A (ja) | 2001-12-27 | 2003-07-09 | Bayer Ag | ピペラジンカルボキシアミド誘導体 |
PT1472225E (pt) * | 2002-02-01 | 2010-07-30 | Euro Celtique Sa | 2-piperazina-piridinas uteis para tratar a dor |
ES2316777T3 (es) | 2002-02-15 | 2009-04-16 | Glaxo Group Limited | Moduladores de receptores vainilloides. |
AU2003301436A1 (en) * | 2002-10-17 | 2004-05-04 | Amgen Inc. | Benzimidazole derivatives and their use as vanilloid receptor ligands |
WO2004080411A2 (fr) * | 2003-03-07 | 2004-09-23 | Neurocrine Biosciences, Inc. | Antagonistes du recepteur de l'hormone concentrant la melanine et compositions et methodes associees |
US20050014753A1 (en) | 2003-04-04 | 2005-01-20 | Irm Llc | Novel compounds and compositions as protein kinase inhibitors |
WO2004103954A1 (fr) * | 2003-05-20 | 2004-12-02 | Ajinomoto Co., Inc. | Derive d'amide |
TWI287010B (en) * | 2003-06-12 | 2007-09-21 | Euro Celtique Sa | Therapeutic agents useful for treating pain |
US7129235B2 (en) * | 2003-07-11 | 2006-10-31 | Abbott Laboratories | Amides useful for treating pain |
US20050009841A1 (en) * | 2003-07-11 | 2005-01-13 | Zheng Guo Zhu | Novel amides useful for treating pain |
NZ544009A (en) * | 2003-07-24 | 2009-07-31 | Euro Celtique Sa | Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain |
DK1648878T3 (da) * | 2003-07-24 | 2009-08-10 | Euro Celtique Sa | Piperidinforbindelser og farmaceutiske sammensætninger, som indeholder dem |
KR20090130422A (ko) * | 2007-04-27 | 2009-12-23 | 퍼듀 퍼머 엘피 | 통증 치료에 유용한 치료제 |
-
2004
- 2004-06-11 TW TW093116961A patent/TWI287010B/zh not_active IP Right Cessation
- 2004-06-11 MY MYPI20042274A patent/MY142655A/en unknown
- 2004-06-11 AR ARP040102043A patent/AR044688A1/es unknown
- 2004-06-14 DK DK07113391T patent/DK1862458T3/da active
- 2004-06-14 EP EP08168291A patent/EP2060260A1/fr not_active Withdrawn
- 2004-06-14 WO PCT/US2004/019189 patent/WO2005004866A1/fr not_active Application Discontinuation
- 2004-06-14 EP EP04776652A patent/EP1631285B1/fr not_active Withdrawn - After Issue
- 2004-06-14 KR KR1020057023740A patent/KR100896497B1/ko not_active IP Right Cessation
- 2004-06-14 AT AT07113391T patent/ATE413385T1/de active
- 2004-06-14 JP JP2006533807A patent/JP5269315B2/ja not_active Expired - Fee Related
- 2004-06-14 BR BRPI0411241-5A patent/BRPI0411241A/pt not_active IP Right Cessation
- 2004-06-14 GE GEAP20049166A patent/GEP20084488B/en unknown
- 2004-06-14 SI SI200431012T patent/SI1862458T1/sl unknown
- 2004-06-14 MX MXPA05013587A patent/MXPA05013587A/es active IP Right Grant
- 2004-06-14 CA CA2528920A patent/CA2528920C/fr not_active Expired - Fee Related
- 2004-06-14 US US10/867,546 patent/US7683063B2/en active Active
- 2004-06-14 PL PL07113391T patent/PL1862458T3/pl unknown
- 2004-06-14 CN CN201010168011A patent/CN101863877A/zh active Pending
- 2004-06-14 AU AU2004255169A patent/AU2004255169B2/en not_active Ceased
- 2004-06-14 EA EA200501820A patent/EA009593B1/ru not_active IP Right Cessation
- 2004-06-14 DE DE602004017658T patent/DE602004017658D1/de not_active Expired - Lifetime
- 2004-06-14 PT PT07113391T patent/PT1862458E/pt unknown
- 2004-06-14 CN CN200480023060XA patent/CN1835751B/zh not_active Expired - Fee Related
- 2004-06-14 ES ES07113391T patent/ES2317623T3/es not_active Expired - Lifetime
- 2004-06-14 KR KR1020087029450A patent/KR20090008439A/ko not_active Application Discontinuation
- 2004-06-14 AT AT04776652T patent/ATE369133T1/de active
- 2004-06-14 EP EP07113391A patent/EP1862458B1/fr not_active Expired - Lifetime
- 2004-06-14 DE DE602004008069T patent/DE602004008069D1/de not_active Expired - Lifetime
-
2005
- 2005-10-28 ZA ZA200508744A patent/ZA200508744B/xx unknown
- 2005-11-23 IS IS8142A patent/IS8142A/is unknown
- 2005-12-06 IL IL172418A patent/IL172418A/en not_active IP Right Cessation
-
2006
- 2006-01-09 MA MA28715A patent/MA27908A1/fr unknown
- 2006-01-12 NO NO20060192A patent/NO20060192L/no not_active Application Discontinuation
-
2009
- 2009-01-30 CY CY20091100110T patent/CY1108738T1/el unknown
-
2010
- 2010-02-16 US US12/706,571 patent/US8227467B2/en not_active Expired - Lifetime
-
2011
- 2011-07-21 JP JP2011159464A patent/JP2012021000A/ja not_active Withdrawn
-
2012
- 2012-06-18 US US13/525,950 patent/US8680118B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA27908A1 (fr) | Agents therapeutiques utiles pour le traitement de la douleur | |
CY1109242T1 (el) | Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου | |
MA26877A1 (fr) | Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant | |
MA28011A1 (fr) | Derives de piperazine et leur utilisation en tant qu'agents therapeutiques | |
TNSN03130A1 (fr) | Inhibiteurs de protease du vih, compositions les contenant, leurs utilisations pharmaceutiques et matieres pour leur synthese | |
MA28009A1 (fr) | Derives de pyridazine et utilisation de ceux-ci en tant qu'agents therapeutiques | |
MA28008A1 (fr) | Derives pyridyle et leur utilisation en tant qu'agents therapeutiques | |
DE60316779D1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
MA31894B1 (fr) | Composes organiques | |
ATE261244T1 (de) | Pharmazeutische zusammensetzungen zur vorbeugung und behandlung der ulzerativen kolitis | |
DE60329316D1 (de) | Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer | |
CY1109037T1 (el) | Πιπεραζινες χρησιμες για θεραπεια πονου | |
WO2005056524A3 (fr) | Agents therapeutiques pour traitement de la douleur | |
TNSN07145A1 (fr) | Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique | |
DE60134245D1 (de) | (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten | |
MA29543B1 (fr) | Procedes pour traiter un cancer pharmacoresistant | |
GEP20022824B (en) | Antipicornaviral Compounds, Pharmaceutical Compositions Containing the Same and Methods for Treatment | |
ATE517861T1 (de) | Benzylether und benzylaminoverbindungen als inhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
TNSN00235A1 (fr) | Derives d'heterocyclo-alkylsulfonylpyrazole nouveaux, procede pour leur preparation et compositions les contenant | |
EP0911331A3 (fr) | Dérivés substitués de dibenzoxazépine, compositions pharmaceutiques et procédés d'utilisation | |
TNSN99111A1 (fr) | Derives de sulfonylbenzene nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
MA26725A1 (fr) | Derives de resorcinol, compositions pharmaceutiques les contenant et procede pour leur preparation | |
FR2869611A1 (fr) | Derives de l'acide hexenoique, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique | |
KR970706811A (ko) | I형 알레르기성 질환의 예방 및 치료제(Preventive and remedy for type Ⅰ allergic diseases) | |
RU2007143434A (ru) | 4-анилино-3-хинолинкарбонитрилы, подходящие для лечения раковых заболеваний |